These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32589135)

  • 1. Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies
.
    Hansrivijit P; Puthenpura MM; Ghahramani N
    Clin Nephrol; 2020 Sep; 94(3):117-126. PubMed ID: 32589135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH; Reiser J; Cara-Fuentes G; Wei C; Matar D; Wang H; Alachkar N; Johnson RJ
    Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
    Hansrivijit P; Cheungpasitporn W; Thongprayoon C; Ghahramani N
    BMC Nephrol; 2020 Apr; 21(1):134. PubMed ID: 32293308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept
.
    Dado D; Parikh S; Ayoub I; Rovin B; Nadasdy T; Hebert L
    Clin Nephrol; 2018 May; 89(5):376-380. PubMed ID: 29249233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.
    Burke GW; Chandar J; Sageshima J; Ortigosa-Goggins M; Amarapurkar P; Mitrofanova A; Defreitas MJ; Katsoufis CP; Seeherunvong W; Centeno A; Pagan J; Mendez-Castaner LA; Mattiazzi AD; Kupin WL; Guerra G; Chen LJ; Morsi M; Figueiro JMG; Vianna R; Abitbol CL; Roth D; Fornoni A; Ruiz P; Ciancio G; Garin EH
    Pediatr Nephrol; 2023 Jan; 38(1):145-159. PubMed ID: 35507150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM; Ezzat DA; Doudar NA; Adel M
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
    Eroglu FK; Orhan D; İnözü M; Duzova A; Gulhan B; Ozaltin F; Topaloglu R
    Pediatr Int; 2019 Dec; 61(12):1250-1256. PubMed ID: 31513327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
    Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ
    Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abatacept in B7-1-positive proteinuric kidney disease.
    Yu CC; Fornoni A; Weins A; Hakroush S; Maiguel D; Sageshima J; Chen L; Ciancio G; Faridi MH; Behr D; Campbell KN; Chang JM; Chen HC; Oh J; Faul C; Arnaout MA; Fiorina P; Gupta V; Greka A; Burke GW; Mundel P
    N Engl J Med; 2013 Dec; 369(25):2416-23. PubMed ID: 24206430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
    Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
    Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
    Pelletier JH; Kumar KR; Engen R; Bensimhon A; Varner JD; Rheault MN; Srivastava T; Straatmann C; Silva C; Davis TK; Wenderfer SE; Gibson K; Selewski D; Barcia J; Weng P; Licht C; Jawa N; Kallash M; Foreman JW; Wigfall DR; Chua AN; Chambers E; Hornik CP; Brewer ED; Nagaraj SK; Greenbaum LA; Gbadegesin RA
    Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
    Gong X; Huang J; Zhang Y; Wang F; Wang X; Meng L; Cheng X; Liu G; Cui Z; Zhao M
    Ren Fail; 2023; 45(2):2279642. PubMed ID: 37942512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
    Meyrier A; Noël LH; Auriche P; Callard P
    Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.
    Delville M; Baye E; Durrbach A; Audard V; Kofman T; Braun L; Olagne J; Nguyen C; Deschênes G; Moulin B; Delahousse M; Kesler-Roussey G; Beaudreuil S; Martinez F; Rabant M; Grimbert P; Gallazzini M; Terzi F; Legendre C; Canaud G
    J Am Soc Nephrol; 2016 Aug; 27(8):2520-7. PubMed ID: 26701979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
    Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
    Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.